FIG 6.

Distribution of responses on treatment guidelines followed before and during the COVID surge among 1,103 respondents regarding a metastatic BC with an enlarging breast mass case 6. A 75-year-old woman with metastatic ER+/PR+/HER2– invasive ductal carcinoma resistant to several lines of systemic therapy presented with an enlarging and bleeding 6-cm right breast mass. Her Karnofsky performance status was 80. Surgical resection was not planned because of the presence of multiple lung metastases. ^aResponses regarding treatment recommendation are shown. BC, breast cancer; ER+, estrogen receptor–positive; HER2–, human epidermal growth factor receptor 2–negative; PR+, progesterone receptor–positive.